Walmart chief medical officer named to NKF board of directors
Click Here to Manage Email Alerts
Key takeaways:
- Wigneswaran was nominated and approved at the NKF board meeting in March.
- He oversees the Walmart Healthcare Research Institute.
The National Kidney Foundation has appointed John Wigneswaran, MD, the chief medical officer of Walmart, to its national board of directors.
“We are excited that Dr. Wig has joined the NKF board of directors and look forward to the wealth of knowledge and expertise he will bring in the areas of safety, quality, training programs, clinical program development and medical affairs,” Tracy McKibben, chair of the national board of NKF, said in a press release. “Dr. Wig is an asset to our board as a health care business leader in many domains and as a nephrologist. We look forward to having him on board as we continue to build greater awareness of kidney disease.”
Wigneswaran, who was nominated and approved at the most recent board meeting of the NKF in March, currently leads safety, quality and training at Walmart, in addition to clinical program development, innovation, medical affairs and overseeing the Walmart Healthcare Research Institute. He has also held previous positions in the pharmaceutical, medical device, pharmacy benefit management and health care services industries, according to the release, including at DaVita, Fresenius Medical Care, Gambro, Nephroceuticals, and Johnson & Johnson.
Wigneswaran began his career as a practicing nephrologist and as a renal fellowship preceptor in the division of nephrology at Rhode Island Hospital/Brown University. He completed his undergrad at Cornell University, medical school at the Tufts University School of Medicine, nephrology fellowship at New York-Presbyterian/Weil Cornell Medical Center and internal medicine residency at Rhode Island Hospital/Brown University. He holds an MBA from Massachusetts Institute of Technology Sloan School of Management.
“I’m honored to join the NKF board of directors and excited to help those dealing with kidney disease in any way I can,” Wigneswaran, said in the release. “I was drawn to nephrology because of the unique needs of the patient population, many in underserved communities, and the opportunity to make an impact. These patients in particular need an advocate, and I wanted to be that individual in their lives.”
Read more about
Click Here to Manage Email Alerts